US Patent Issued to Arrowhead Pharmaceuticals on Jan. 20 for "Anti-transferrin receptor antibodies, conjugates thereof, and uses thereof" (Wisconsin, California, Illinois Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,877, issued on Jan. 20, was assigned to Arrowhead Pharmaceuticals Inc. (Pasadena, Calif.).

"Anti-transferrin receptor antibodies, conjugates thereof, and uses thereof" was invented by Agnieszka Glebocka (Madison, Wis.), Zhao Xu (San Diego), Jeffrey Carlson (Madison, Wis.), Jingdong Ye (Lincolnshire, Ill.) and Matthew Fowler-Watters (Madison, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a transferrin receptor (TfR1) antibody for conjugation to therapeutic payloads. The TfR1 antibodies may be used for delivering the therapeutic payloads, for instance oligonucleotide-based agents, to CNS tissues, skeletal muscle tissues, o...